¤¢¤Ê¤¿¤ÎÈéÉæ¤ÎEGF¤ÏÂ¤ê¤Æ¤¤¤Þ¤¹¤«¡©

¤ä¤Ã¤Ñ¤ê»ä¤Ë¤Ï¤³¤ì¤¬¹ç¤Ã¤Æ¤¤¤ë¡£
»Å»ö¤¬¥Ï¡¼¥É¤Çξ¦ˡÎá¤Ó¤Ã¤·¤ê¡¦¡¦¡¦¤Ê»þ¤Ë»È¤Ã¤Æ¤¹¤´¤¤¸ú²Ì¡¦Â¨¸úÀ¤Ç¡¢¤ß¤ë¤ß¤ëÈ©¤¬¼ãÊ֤ꤽ¤ì¤«¤éκ¤Ë¤Ê¤Ã¤¿¡¦¡¦¡¦

¤Û¤ó¤È¤³¤³¤Þ¤ÇÈ©¤¬¸µ¤ËÌá¤ë¤È¤Ï»×¤¤¤â¤·¤Ê¤«¤Ã¤¿¤±¤É¡£¡£
¤³¤ì¡¢Æ±¤¸¤¯¤ªÈ©¤ÎÏ·²½¤¬¤Ò¤É¤¤¿Í¤Ë»È¤Ã¤Æ¤â¤é¤¤¤¿¤¤¡£¡£¤È¤¤¤¦¤«¡¢¸ú¤¯¤È»×¤¦¡£
EGF¥¨¥¯¥¹¥È¥é¥¨¥Ã¥»¥ó¥¹


PARS¡¡EGF¥¨¥Ã¥»¥ó¥¹¥Õ¥¡¥ó¥Ö¥í¥¬¡¼¥µ¥¤¥È¤Ë»²²ÃÃæ
£È§²Ë¬ÌäŽ±ŽØŽ¶ŽÞÅ

¥é¥ó¥¥ó¥°¤Ë»²²Ã¤·¤Æ¤Þ¤¹¡£
¢¡¡¥Ý¥Á¤Ã¤È±þ±ç¤ª´ê¤¤¤¤¤¿¤·¤Þ¤¹

¿Íµ¤¥Ö¥í¥°¥é¥ó¥¥ó¥°¤Ø
¤¤¤Ä¤â¤¢¤ê¤¬¥È¥ó
¤³¤ì¤Þ¤¨¤Ë¤â¸½ÉÊ¹ØÆþ¤·¤¿¤³¤È¤¬¤¢¤ë¤Î¤Ç2ËÜÌܤǤ¹


»ä¤³¤Á¤é¤Î¥á¡¼¥«¡¼¤Î¥Ñ¡¼¥¹¤µ¤ó¡¢Âç¹¥¤¤Ê¤ó¤¹¤¬

¡Ø¼«Ê¬¤ä²È²¤¬°Â¿´¤·¤Æ»È¤¨¤Ê¤¤¤â¤Î¤ÏÃǸǤȤ·¤ÆÀ½Éʳ«È¯¤½¤·¤ÆÈÎÇä¤Ï¤·¤Ê¤¤¡Ù¤È¤¤¤¦¡¢´è¸Ç¤Ê¤³¤À¤ï¤ê¤ò¤â¤¿¤ì¤Æ¤¤¤ë¡£
¤½¤·¤Æ¤³¤ì¤«¤é¤â¤º¤Ã¤È¼é¤êÄ̤½¤¦¤È»×¤Ã¤Æ¤ª¤é¤ì¤ë¤È¤Î¤³¤È¤Ç¤¹¡£
»ä¤³¤¦¤¤¤¦¥á¡¼¥«¡¼¤µ¤ó¤Ï¡¢¤«¤Ê¤ê±þ±ç¤·¤¿¤¯¤Ê¤ë¡£
Çä¤ì¤ê¤ã¤Ê¤ó¤Ç¤â¤¤¤¤¡£ÂΤ˰¤¤¤â¤Î¤Ç¤âÌÙ¤±¤µ¤¨¤Ç¤ì¤Ð¡¦¡¦¡¦¤È¤¤¤¦¥á¡¼¥«¡¼¤À¤Ã¤Æ¼ÂºÝ¤¢¤ë¤¸¤ã¤Ê¤¤¡©
¤Æ¤¤¤¦¤«¡¢Â¿¤¤¤Èʹ¤¯¡£
¤½¤ì¤Ë¡¢ÉԻ׵Ĥʤ³¤È¤Ë¤½¤¦¤¤¤Ã¤¿¡¦¡¦¡¦¤Ê¥á¡¼¥«¡¼¤Î¥³¥¹¥á¤Û¤É¹â¤¯¡¢ÎÉ¿´Åª¤Ê¥á¡¼¥«¡¼¤µ¤ó¤Î¥³¥¹¥á¤Û¤É°Â¤¯Çä¤é¤ì¤Æ¤¤¤ë¤È¤«¡£¡Ê¤É¤³¤«¤Ç¥³¥¹¥á¤Î˽Ϫ¤ß¤¿¤¤¤Ê¤Î¤òÆÉ¤ó¤À¡Ë
¤½¤ó¤Ê¤³¤È¤Ï¤ª¤¤¤È¤¤¤Æ¡£
¤³¤Á¤é¤ÎEGF

PARS EGF¥¨¥¯¥¹¥È¥é¥¨¥Ã¥»¥ó¥¹¤Ï¡¢h-EGF(¥Ò¥È¥ª¥ê¥´¥Ú¥×¥Á¥É-1 ÈéÉæºÆÀ¸Áý¿£°ø»Ò)¤òÇ۹礷¤¿¡¢Àö´é¸å¤¹¤°¤Ë»ÈÍѤ¹¤ë¿·´¶³Ð¤ÎÈþÍÆ±Õ¡£
¥ª¥¤¥ë¡¢³¦Ì̳èÀºÞ¡¢¹çÀ®Ãå¿§ÎÁ¡¢¹áÎÁ¡¢¥Ñ¥é¥Ù¥ó¤ÏÇ۹礵¤ì¤Æ¤Þ¤»¤ó¡£
¤â¤¦ÃΤé¤Ê¤¤¿Í¤Ï¤¤¤Ê¤¤¤Î¤«¤â¤·¤ì¤Þ¤»¤ó¤¬¡¢¾¯¤·ÀâÌÀ¤ò¡£¡£¡£
h-EGF¤È¤ÏHuman Epidermal Growth Factor(ÈéÉæºÆÀ¸Áý¿£°ø»Ò)¤Îά¾Î¤Ç¤¹¡£
h-EGF¤Ï¿Í´Ö¤¬¤â¤Ã¤Æ¤¤¤ë¥¿¥ó¥Ñ¥¯¼Á¤Î°ì¼ï¤Ç¡¢1996ǯ¤ËÊÆ¹ñ¤ÎDr.¥³¡¼¥¨¥ó¤¬È¯¸«¤·¡¢¤½¤Î¸ùÀӤˤè¤ê¡¢¥Î¡¼¥Ù¥ë°å³ØÀ¸Íý³Ø¾Þ¤ò¼õ¾Þ¡£
EGF¤Ï¡¢¤â¤È¤â¤È¿Í´Ö¤Ë¤¢¤ëÀ®Ê¬¤Ç¤¹¤¬¡¢Ç¯Îð¤ò½Å¤Í¤ë¤Ë¤·¤¿¤¬¤Ã¤ÆÊ¬ÈçÎ̤¬¸º¾¯¤·¡¢È©¤ÏÏ·²½¤·¤Æ¤¤¤¤Þ¤¹¡£
¤Ç¤¹¤«¤é¡¢EGF¤òÊäµë¤¹¤ë¤³¤È¤Ë¤è¤ê¡¢Ç¯Îð¤È¤È¤â¤ËÄã²¼¤¹¤ëÈ©ËÜÍè¤ÎÎϤò½õ¤±¡¢ÈéÉæËÜÍè¤Î¥Ï¥ê¤È¥Ä¥ä¡¢¼ã¡¹¤·¤µ¤ò¼è¤êÌ᤹¤³¤È¤¬¤Ç¤¤ë¤Î¤Ç¤¹¡£
EGF¤ÏɬÍװʾå¼è¤ê¹þ¤Þ¤ì¤ë¤³¤È¤¬¤Ê¤¯¡¢ÉûºîÍѤΤʤ¤°ÂÁ´¤ÊÀ®Ê¬¤Ç¤¹¡£
ÆâÍÆÀ®Ê¬
¿å¡¢BG¡¢¥Ò¥È¥ª¥ê¥´¥Ú¥×¥Á¥É¡Ý1¡¢¥Ò¥¢¥ë¥í¥ó»ÀNa¡¢¿åÍÏÀ¥³¥é¡¼¥²¥ó¡¢¥Þ¥ó¥Ë¥È¡¼¥ë¡¢¥¯¥¨¥ó»À¡¢¥¯¥¨¥ó»ÀNa¡¢¥Õ¥§¥Î¥¥·¥¨¥¿¥Î¡¼¥ë
ÆâÍÆÎÌ 60ml
¤³¤ìEGFÈþÍÆ±Õ¤ÎÃæ¤Ç¤Ï¥µ¥é¥Ã¤È¤·¤Æ¤¤¤ë¤Î¤Ç¡¢»Ï¤á¤Ïʪ¤ê¤Ê¤¯´¶¤¸¤ë¤«¤â¡©
»ä¤âÏ·²½¤¬·ã¤·¤¤¾õÂ֤ǻȤä¿»þ¤Ï¡¢¥µ¥é¥Ã¤È¤·¤Æ¤¤¤Æ¤Ê¤ó¤À¤«½á¤ï¤Ê¤¤¤·¡¦¡¦¡¦¤È²¿ÅÙ¤â½Å¤Í¤Å¤±¤·¤Æ½á¤ï¤·¤Æ¤¤¤Þ¤·¤¿¤¬¡£¡£
¤Ä¤¤¤³¤ÎÁ°¥µ¥ó¥×¥ë¤ò»È¤ï¤»¤Æ¤¤¤¿¤À¤¤¤¿»þ¤Ï¡¢¤Ï¤¸¤á¤«¤é¾¯Î̤Ǥ·¤Ã¤È¤ê¤·¤ÆÇÛ¹ç¤ò²¿¤«ÊѤ¨¤¿¤Î¤«¤È»×¤Ã¤¿¤Û¤É¡£¡Ê²þÎɤϤ·¤Æ¤¤¤Ê¤¤¤È¤Î¤³¤È¤Ç¤¹¡Ë
¤³¤Î¤è¤¦¤Ë¡¢È©¤Ë¤Ä¤Ã¤Ñ¤ê´¶¤¬¤¢¤ë¾ì¹ç¤Ï¡¢È©¤¬EGF¤òÍߤ·¤Æ¤¤¤ë¾õÂ֤ʤΤǡ¢½Å¤ÍÉÕ¤±¤·¤Æ¤¯¤À¤µ¤¤¤È¤Î»ö¡£
¤â¤È¤â¤ÈEGF¤¬Ä¹Ç¯¾¯¤Ê¤¤¾õÂ֤Ǥϡ¢½é¤á3Å٤ۤɤνŤÍÉÕ¤±¤¬É¬Íפʾì¹ç¤¬¤¢¤ê¡¢¿ôÆü¸å¤Ë¤Ï¡¢¤½¤ì¤Þ¤Ç¤Î¤è¤¦¤ËÈ©¤ËÆþ¤é¤Ê¤¯¤Ê¤ê¡¢1ÅÙ¤ÎÅÉÉۤǡ¢È©¤¬¤â¤Ã¤Á¤ê¤È¤¹¤ë¤Î¤¬¡¢´¶¤¸¤é¤ì¤ë¤è¤¦¤Ë¤Ê¤ë¤È¤Î¤³¤È¡£
¤³¤ì¡¢¼«Ê¬¤ÎÈ©¤¬Ï·²½¤¬·ã¤·¤¤¤Î¤«¡ÊEGF¤¬Â¤ê¤Æ¤¤¤Ê¤¤¤Î¤«¡Ë»È¤Ã¤Æ¤ß¤ë¤È¤ï¤«¤ë¤«¤â¡£¡£
¤Þ¤¨¤Ë¥µ¥ó¥×¥ë¤ò»È¤Ã¤¿»þ¤Ë¤Ï¡¢Ë¡Îᡦ¥·¥ï¡¦¥Ë¥¥Ó¡¦¤Ê¤É¤Ë¤«¤Ê¤ê¤Î¨¸úÀ¤ò´¶¤¸¤é¤ì¡¢Â¨¸½Éʤò¹ØÆþ¤·¤¿¤ó¤Ç¤¹¤¬¡°¡°
µÕ¤Ë¤¤¤¨¤Ð¡¢Ï·²½¤¬·ã¤·¤¯¤Ê¤¤¿Í¤Ë¤Ï¡¢Â¨¸úÀ¤Ï´¶¤¸¤é¤ì¤Ê¤¤¤Î¤«¤â¡£¡£
¤Ç¤â¤³¤ìÏ·²½Í½Ëɤˤ⤫¤Ê¤ê¸ú²Ì¤òȯ´ø¤·¤Æ¤¯¤ì¤ë¤Î¤Ç¡¢Í½Ëɤ˻Ȥ¦¤Î¤â¼ê¤À¤è

¤â¡Áº£¤¹¤°¤Ë¤Ç¤â»È¤¤¤¿¤¤¤¯¤é¤¤¤Ç¤¹¤¬¡¢º£Â¾¤ÎEGFÈþÍÆ±Õ»ÈÍÑÃæ¤Ê¤Î¤Ç¡¢¤â¤Ã¤È¸å¤Ë¤Ê¤Ã¤Æ¤·¤Þ¤¤¤½¤¦¡¦¡¦¡¦

º£²ó¤Ï¾Ò²ð¤À¤±¤Ç¡¦¡¦¡¦¡£
¥Ñ¡¼¥¹¤µ¤ó¤Ë¤â¿½¤·Ìõ¤Ê¤¤¤ó¤Ç¤¹¤¬¡¦¡¦¡¦

³«Éõ¸å¤ÏEGF¤Î³èÀ¤¬Íî¤Á¤ë¤½¤¦¤Ê¤Î¤Ç¡¢ºÇÄã¤Ç¤â3¥ö·î¤Ç»È¤¤Àڤ俤ۤ¦¤¬¤¤¤¤¤½¤¦¤Ê¤ó¤Ç¤¹¤è¤Í¤§¡£¡£
º£»È¤Ã¤Æ¤¤¤ë¤â¤Î¤òµÞ¤¤¤Ç»È¤¤Àڤꡢ¤³¤Á¤é¤Î¥ì¥Ý¤âÁá¤á¤Ë¤·¤¿¤¤¤È»×¤Ã¤Æ¤¤¤Þ¤¹¤Î¤Ç¡¦¡¦¡¦¡£

¤³¤Á¤é¡¢anan¡¢¥¯¥í¥ï¥Ã¥µ¥ó¡¢UP¡¢MORE¡¢¤Ê¤É¤ÎÍÍ¡¹¤Ê¥á¥Ç¥£¥¢¤Ç¾Ò²ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡°¡°
´°Á´Å·Á³Í³ÍèÈþÍÆ±Õ

¡úºòÆü¤Ï¥À¥Ã¥¯¥¹¤Î¥Õ¥£¥é¥ê¥¢¤Î¸¡ºº¤Ë¹Ô¤Ã¤Æ¤¤Þ¤·¤¿

·ì±Õ¤òºÎ¤Ã¤ÆÄ´¤Ù¤Æ¤â¤é¤¦¤ó¤Ç¤¹¤¬¡¢¤¦¤Á¤Î¥À¥Ã¥¯¥¹¤ª¤È¤Ê¤·¤¯²æËý¶¯¤¤»Ò¤Ê¤Î¤Ç¡Ê¿Æ¤Ð¤«È¯¸À¡Ë¡¢Á´Á³Ë½¤ì¤º¤¹¤ó¤Ê¤êºÎ¤é¤»¤Æ¤Þ¤·¤¿

¤¦¤Á¤Î¤Û¤¦¤Ï1·î¤Þ¤Ç²ã¤¬Èô¤ó¤Ç¤¤¤¿¤·¡¢3·î¤Ë¤â¸«¤«¤±¤Æ¤¤¤¿¤Î¤Ç¡¢¤Á¤ç¤Ã¤È¿´ÇÛ¤À¤Ã¤¿¤ó¤Ç¤¹¤¬¡£¡£¡£
Âç¾æÉפǤ·¤¿¡°¡°
¤³¤ó¤Ê¤Ë²ã¤¬¤¤¤ë¤Î¤Ã¤Æ¡¢»ä¤Î½»¤ó¤Ç¤¤¤ë¤È¤³¤í¤À¤±¤Ê¤Î¤«¤Ê¤¡¡©¡©
¤³¤ì¤¸¤ãÇ¯Ãæ¥Õ¥£¥é¥ê¥¢¤ÎÌôɬ¿Ü¤Ë¤Ê¤Ã¤Á¤ã¤¦¤ó¤¸¤ã¡¦¡¦¡¦

£È§²Ë¬ÌäŽ±ŽØŽ¶ŽÞÅ

¥é¥ó¥¥ó¥°¤Ë»²²Ã¤·¤Æ¤Þ¤¹¡£
¢¡¡¥Ý¥Á¤Ã¤È±þ±ç¤ª´ê¤¤¤¤¤¿¤·¤Þ¤¹

¿Íµ¤¥Ö¥í¥°¥é¥ó¥¥ó¥°¤Ø
¤¤¤Ä¤â¤¢¤ê¤¬¥È¥ó





























´ÉÍý¿Í¤Î¤ß±ÜÍ÷¤Ç¤¤Þ¤¹